middle.news
Avecho Nears Key Milestone in CBD Insomnia Trial Recruitment
10:51am on Thursday 18th of December, 2025 AEDT
•
Biotechnology
Read Story
Avecho Nears Key Milestone in CBD Insomnia Trial Recruitment
10:51am on Thursday 18th of December, 2025 AEDT
Key Points
190 of 210 patients dosed in Phase III CBD insomnia trial
Recruitment extended due to strict participant criteria
Interim analysis timeline to be confirmed post-recruitment
Trial designed to meet Australian, US, and European regulatory standards
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE